What does CUSIP 921659108 represent in this 13F holders report?

CUSIP 921659108 is the security identifier for VNDA - Vanda Pharmaceuticals Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held VNDA - Vanda Pharmaceuticals Inc. - COMMON STOCK in Q2 2023?

187 institutional investors reported VNDA - Vanda Pharmaceuticals Inc. - COMMON STOCK for Q2 2023. Use the holders table for investor-level position and value details.

Vanda Pharmaceuticals Inc. - COMMON STOCK (VNDA)

CUSIP: 921659108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / COMMON STOCK
Shares outstanding: 59,128,667
Total 13F shares: 56,248,075
Share change: -2,133,657
Total reported value: $370,694,666
Put/Call ratio: 150%
Price per share: $6.59
Number of holders: 187
Value change: -$14,253,028
Number of buys: 95
Number of sells: 73

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 921659108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	17%	10,098,930	$68,571,734	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	7.7%	4,551,912	$30,907,482	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	7%	4,128,114	$28,029,894	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	5%	2,935,225	$19,930,000	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	4.7%	2,783,690	$18,900,993	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	3%	1,761,728	$11,962,000	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	2.8%	1,650,937	$11,209,862	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	2.8%	1,631,140	$11,075,441	—	31 Mar 2023	13F
Assenagon Asset Management S.A.	13F	Company	2.7%	1,587,717	$10,780,598	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	2.3%	1,363,097	$9,255,429	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	2.1%	1,249,606	$8,484,824	—	31 Mar 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	2.1%	1,217,817	$8,268,977	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.8%	1,082,531	$7,350,390	—	31 Mar 2023	13F
PRUDENTIAL FINANCIAL INC	13F	Company	1.8%	1,063,909	$7,223,942	—	31 Mar 2023	13F
FEDERATED HERMES, INC.	13F	Company	1.8%	1,044,777	$7,094,036	—	31 Mar 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.8%	1,038,842	$7,049,000	—	31 Mar 2023	13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC	13F	Company	1.7%	1,031,860	$7,006,329	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	1.7%	1,018,201	$6,913,585	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.7%	991,045	$6,729,197	—	31 Mar 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	1.5%	896,507	$6,087,283	—	31 Mar 2023	13F
Allspring Global Investments Holdings, LLC	13F	Company	1.3%	797,392	$5,414,291	—	31 Mar 2023	13F
Epoch Investment Partners, Inc.	13F	Company	1.2%	706,570	$4,797,610	—	31 Mar 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	688,337	$4,673,808	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	1.1%	632,357	$4,293,704	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	1%	596,283	$4,048,762	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	1%	593,688	$4,032,000	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.98%	577,400	$3,920,546	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.86%	510,995	$3,469,656	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.86%	508,256	$3,451,058	—	31 Mar 2023	13F
Palo Alto Investors LP	13F	Company	0.82%	482,697	$3,277,513	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	0.62%	368,839	$2,504,417	—	31 Mar 2023	13F
Krensavage Asset Management, LLC	13F	Company	0.61%	361,560	$2,455,000	—	31 Mar 2023	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.59%	350,768	$2,381,714	—	31 Mar 2023	13F
Profit Investment Management, LLC	13F	Company	0.56%	332,863	$2,260,140	—	31 Mar 2023	13F
Walleye Capital LLC	13F	Company	0.53%	315,369	$2,141,356	—	31 Mar 2023	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.4%	238,125	$1,616,869	—	31 Mar 2023	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.4%	235,644	$1,600,023	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.39%	230,086	$1,562,284	—	31 Mar 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.38%	224,150	$1,521,979	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.38%	221,850	$1,506,362	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.35%	207,872	$1,411,000	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.33%	193,608	$1,315,000	—	31 Mar 2023	13F
SEI INVESTMENTS CO	13F	Company	0.32%	190,492	$1,293,445	—	31 Mar 2023	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.31%	184,145	$1,250,345	—	31 Mar 2023	13F
FRANKLIN RESOURCES INC	13F	Company	0.28%	162,751	$1,105,080	—	31 Mar 2023	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.27%	162,002	$1,099,994	—	31 Mar 2023	13F
NORGES BANK	13F	Company	0.27%	159,000	$1,079,610	—	31 Mar 2023	13F
HUSSMAN STRATEGIC ADVISORS, INC.	13F	Company	0.26%	156,000	$1,059,240	—	31 Mar 2023	13F
CAXTON ASSOCIATES LP	13F	Company	0.26%	153,384	$1,041,477	—	31 Mar 2023	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.25%	149,809	$1,017,203	—	31 Mar 2023	13F

Institutional Holders of Vanda Pharmaceuticals Inc. - COMMON STOCK (VNDA) as of Q2 2023

As of 30 Jun 2023, Vanda Pharmaceuticals Inc. - COMMON STOCK (VNDA) was held by 187 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,248,075 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, DIMENSIONAL FUND ADVISORS LP, Assenagon Asset Management S.A., PICTET ASSET MANAGEMENT SA, D. E. Shaw & Co., Inc., and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC. This page lists 187 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

176

Q2 2023 holders

187

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.